Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00221468 · ClinicalTrials.gov registry record · Phase 3
A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
A Phase 3 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT00221468 is a Phase 3 study that has completed, run by University of Cincinnati. The registered enrollment target is 20 participants.
The verdict
NCT00221468, a Phase 3 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to obtain preliminary data regarding the effectiveness, tolerability, and safety of quetiapine therapy for adolescents who have a mood disorder and have at least one parent with bipolar disorder (severe mood swings).
Interventions
- DRUG quetiapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00221468
The ClinicalTrials.gov registry entry for NCT00221468 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which quetiapine is the first listed.
NCT00221468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00221468 about?
NCT00221468 is a clinical study titled "A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents". The purpose of this research study is to obtain preliminary data regarding the effectiveness, tolerability, and safety of quetiapine therapy for adolescents who have a mood disorder and have at least one parent with bipolar disorder (severe mood swings).
What is the current status of trial NCT00221468?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2003-06. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00221468?
The interventions under investigation include: quetiapine (DRUG).
Who is sponsoring clinical trial NCT00221468?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.